Influenza

>

Latest News

 High-Dose Influenza Vaccine Reduces Risk of Myocarditis and Pericarditis in Older Adults / Image credit: University of Copenhagen
High-Dose Influenza Vaccine Reduces Risk of Myocarditis and Pericarditis in Older Adults

September 5th 2025

A secondary analysis of the DANFLU-2 trial found adults ≥65 receiving a high-dose flu vaccine had a 46% lower risk of myocarditis or pericarditis compared with standard-dose vaccination.

American Academy of Pediatrics Counters CDC with Updated Childhood Immunization Schedule / image Susan Kressly, MD
American Academy of Pediatrics Counters CDC with Updated Childhood Immunization Schedule

August 20th 2025

Preparing for the 2025-26 Respiratory Virus Season: A Q&A With Sarah Sams, MD
Preparing for the 2025-26 Respiratory Virus Season: A Q&A With Sarah Sams, MD

August 18th 2025

FluMist Intranasal Flu Vaccine Now Available for At-Home Delivery and Self-Administration
FluMist Intranasal Flu Vaccine Now Available for At-Home Delivery and Self-Administration

August 18th 2025

Combating Vaccine Misinformation: Q&A With Amesh Adalja, MD
Combating Vaccine Misinformation: Q&A With Amesh Adalja, MD

August 14th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.